MRIGlobal Blog
Search Blogs
Showing 61–72 of 216
-
Emerging and Re-emerging Chemical Threats (part 2)
Chemical weapons. Some might read that and think they’re a relic of the past. A technology reserved for history that is buried in books and that has given way to more modern weapons and warfare. In part, that may be because the first use of blister agents in World War I occurred more than 100 […]
Analytical Chemistry CBRNE Research & CTI Chemical Threats -
Detection Equipment to Address the Drug Crisis
One every five minutes, totaling 109,680 people (that’s enough to fill a Boeing 747 nearly 300 times). That’s how many people died in 2022 from a drug overdose in the United States, according to data released by the Centers for Disease Control and Prevention. That’s up from 107,000 people in 2021, hitting a new annual […]
Analytical Chemistry CBRNE Research & CTI Chemical Threats -
New Generation Method Delivers Clean Vapor Profiles
When developing a reference library to work with nerve agents like Novichok and blister agents like sulfur mustard, creating clean vapor profiles is essential. Doing so enables accurate testing of existing and new technologies to identify these chemical agents. Clean vapor profiles may also be used to expose materials for subsequent decontamination tests. Our new […]
CBRNE Research & CTI Chemical Threats Detection & Defeat -
MRIGlobal Celebrates STEM Day
November 8 is National STEM Day, the unofficial holiday that celebrates science, technology, engineering, and mathematics (STEM) education throughout the United States. MRIGlobal supports several STEM-related activities that benefit students from the communities in which we work, play, and live. As we approach our 80th anniversary in 2024, we look forward to continuing our stewardship […]
-
How Can Wastewater Testing Help Track SARS-CoV-2 Variants?
The names are likely familiar to you: Alpha, Beta, Delta, Gamma, and Omicron. But rapidly identifying the what, when, and where these and other viral variants of SARS-CoV-2 emerge is critical to help speed the public health response. Whole genome sequencing is an option for surveillance of the virus; however, it is still in its […]
Assay & Method Development Biological Threats Field-Forward Pathogen Detection -
Testing a SARS-CoV-2 Assay at 20,000 Feet
As part of an application for 510(k) approval, the U.S. Food and Drug Administration (FDA) requires assay developers to provide data on how their assay performs under a variety of less-than-optimal conditions. These tests are called flex studies and are generally standardized for all similar device submissions. For instance, will the assay still work after […]
Assay & Method Development Regulatory Strategy & Submissions Verification & Validation -
Assay Testing in Our CAP/CLIA Laboratory
Our College of American Pathologist (CAP) accredited and Clinical Laboratory Improvement Amendments (CLIA) certified (CAP/CLIA) laboratory was utilized during the COVID-19 pandemic for the detection of SARS-CoV-2. In early 2020, the laboratory offered a single COVID-19 test – the Centers for Disease Control (CDC) 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, which was also known […]
Assay & Method Development Clinical Study Strategy & Execution Verification & Validation -
Beyond the Plague Doctor – What are Biosafety and Biosecurity?
The Plague Doctor, a 16th century picture, with broad-brimmed hat, hands covered with long, curving fingernails, body covered with a waxed robe, mask with goggled eyes, and a bizarrely pointed beak portrays a striking and fearsome appearance. Despite the unusual and rather fearsome appearance, the Plague Doctor’s personal protective equipment (“PPE”) is an early example […]
Biosafety & Biosecurity Biosafety & Biosecurity Consulting - Laboratory Biosafety & Biosecurity Consulting - Strategy -
MRIGlobal Launches New Science Podcast
“Science Diction” Profiles Innovative Scientific and Engineering Research MRIGlobal has launched the new “Science Diction” podcast focused on our science, the scientists and engineers responsible for this work, and its positive impact around the world. Twice each month, MRIGlobal’s Chief Innovation Officer Dr. Amy Manning-BoÄŸ will have a conversation with scientific researchers and engineers from […]
Health & National Security Pharmaceutical RUO to IVD Product Development -
Testing Infectious Disease Diagnostics at MRIGlobal
The COVID-19 pandemic caught the world by surprise, and scientists worked collectively to develop new diagnostic tests, treatments, and vaccines. In response to the pandemic, the National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx®) initiative to hasten the development, commercialization, and implementation of novel diagnostic tests for SARS-CoV-2, the virus that […]
Assay & Method Development Regulatory Strategy & Submissions Verification & Validation -
Supporting In Vitro Diagnostic Developers
When the COVID-19 pandemic was declared by the WHO (World Health Organization) in the spring of 2020, public health officials were rapidly seeking diagnostic testing solutions to help address the public health crisis. The diagnostic field witnessed a large infusion of support at that time, as funds were allocated for In Vitro Diagnostic (IVD) devices […]
Assay & Method Development Biological Threats RUO to IVD Product Development -
What to Expect from COVID-19 this Fall
(As some of the points within are time-sensitive, an editor’s note that the information within was current as of Monday, Sept. 25) In Nov. 2022, we asked the question “Is the Pandemic Really Over?”, and profiled our role in combatting COVID-19, our support for at-home testing, and our preparations for what is next. Jump ahead […]
Biological Threats Detection & Diagnostics Preparedness & Response
